• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Drug Delivery

Youtubes front page on a laptop screen but the photo is at an angle obscuring most of the the thumbnails
Marketing

Neurotech turns to YouTube for rare eye disorder campaign

As Neurotech looks to ramp up the launch of its first-ever commercial product, the biopharma is running a new video series to help boost awareness.
Ben Adams Jun 3, 2026 9:32am
John JJson  Johnson

J&J bladder cancer survey shows toll of surgery, BCG treatment

May 14, 2026 4:00pm
graphic art of a right hand signing something

Biogen taps Alteogen for help developing 2 subQ biologics

Mar 25, 2026 10:55am
failure crash no fail rocket cancelled end

Quince explores options after ph. 3 rare disease flop

Jan 30, 2026 10:44am
Illustration connected puzzle pieces with the acronym MA

Halozyme catches M&A wave to snap up Surf Bio

Jan 28, 2026 2:06pm
liver

Bausch tumbles as new version of Xifaxan fails ph. 3 trials

Jan 23, 2026 10:21am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings